Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 HPV positivity and immunohistochemistry markers in cervical adenocarcinomas (ADC)

From: The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervix

  Adenocarcinoma (ADC)
HPV positivity 48.1% (13/26)
p16 ≥ 75% 57.7% (15/26)
CEA > 10% 48.0% (12/25)
Vimentin ≥ 20% 23.1% (6/26)
ER ≥ 10% 0.0% (0/26)
PR ≥ 10% 7.7% (2/26)